ACUTE MYELOID LEUKEMIAS
Clinical trials for ACUTE MYELOID LEUKEMIAS explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIAS trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to beat tough leukemia
Disease control Recruiting nowThis phase 3 trial tests whether adding the drug revumenib to standard intensive chemotherapy helps people with newly diagnosed acute myeloid leukemia (AML) that has a specific genetic change (NPM1 mutation). About 468 participants will receive either revumenib or a placebo along…
Matched conditions: ACUTE MYELOID LEUKEMIAS
Phase: PHASE3 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for tough blood cancers: first human trial launches
Disease control Recruiting nowThis study tests a new drug called STX-0712 in people with advanced types of blood cancer (CMML or AML) who have run out of standard treatments. The main goal is to find a safe dose and see how the body handles the drug. About 105 participants will take part in this early-phase t…
Matched conditions: ACUTE MYELOID LEUKEMIAS
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC